Imprimis NJOF, LLC recalls Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 W
Recalled January 6, 2021 · FDA recall D-0177-2021 · Imprimis NJOF
Hazard
Lack of assurance of sterility: 13 vials were discovered to have faulty crimps. · FDA Class II
Units
6520 vials
Sold at
U.S.A. Nationwide
Description
Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.
Product
Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ - 07852 (844)446-6979
Manufacturer(s)
Imprimis NJOF, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →